Human Longevity Stock | BioTech | Founded: 2013 | Funding to Date: $49,298,124

Human Longevity, Inc. (HLI) is the genomics-based, technology-driven company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries to revolutionize the practice of medicine. HLI’s business also includes the HLI Health Nucleus, a genomic powered clinical research program which uses whole genome sequence analysis, advanced clinical imaging and innovative machine learning, along with curated personal health information, to deliver the most complete picture of individual health.

ENTERPRISE VALUE (based on primary fundings)

Key Investors
Amino Capital
Draper Fisher Jurvetson
GE Ventures
Synthetic Genomics
StartUp Health


Management Team
  • J. Venter - Co-founder and CEO
  • Yaron Turpaz - Chief Information Officer
  • Felix Frueh - Chief Scientific Officer
  • Williams Biggs - Head, Genomic Sequencing
Board Members
  • Eric Anderson - Intentional Software
  • David Brenner - University of California, San Diego
  • James Brewer - University of California, San Diego
  • Delos Cosgrove - Cleveland Clinic